PIK3CA-RELATED OVERGROWTH SPECTRUM
Clinical trials for PIK3CA-RELATED OVERGROWTH SPECTRUM explained in plain language.
Never miss a new study
Get alerted when new PIK3CA-RELATED OVERGROWTH SPECTRUM trials appear
Sign up with your email to follow new studies for PIK3CA-RELATED OVERGROWTH SPECTRUM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
French hospital data reveals hidden numbers of rare PROS patients
Knowledge-focused CompletedThis study looked at hospital records from 2015 to 2022 to find out how many people in France have a rare genetic condition called PROS. Researchers analyzed data from over 3,600 patients to understand their age, where they live, and what other health problems they have. The goal…
Matched conditions: PIK3CA-RELATED OVERGROWTH SPECTRUM
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 06:49 UTC
-
French registry sheds light on mysterious overgrowth disorders
Knowledge-focused CompletedThis study created the first French national registry for rare overgrowth syndromes, such as CLOVES and Klippel-Trenaunay syndrome. Researchers collected medical and genetic information from 28 children and adults to better understand these conditions and estimate how many people…
Matched conditions: PIK3CA-RELATED OVERGROWTH SPECTRUM
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 13, 2026 16:02 UTC